OverviewSuggest Edit

Quidel is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Quidel's diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases.

TypePublic
Founded1979
HQSan Diego, CA, US
Websitequidel.com
Employee Ratings3.5
Overall CultureF

Latest Updates

Employees (est.) (Dec 2019)1,250(+3%)
Job Openings74
Revenue (FY, 2020)$1.7 B(+211%)
Share Price (Jun 2021)$114.8
Cybersecurity ratingBMore

Key People/Management at Quidel

Douglas C. Bryant

Douglas C. Bryant

Director, President and Chief Executive Officer
Ratan Borkar

Ratan Borkar

SVP, International Commercial Operations
Robert J. Bujarski

Robert J. Bujarski

Chief Operating Officer
Matthew W. Strobeck

Matthew W. Strobeck

Director
Michael D. Abney

Michael D. Abney

SVP, North American Sales & Distribution
Randall J. Steward

Randall J. Steward

Chief Financial Officer
Show more

Quidel Office Locations

Quidel has offices in San Diego, Athens, Beverly, Kornwestheim and in 1 other location
San Diego, CA, US (HQ)
12544 High Bluff Dr
Athens, OH, US
2005 E State St
Athens, OH, US
2005 E State St #100
Beverly, MA, US
500 Cummings Center #5550
San Diego, CA, US
10165 McKellar Ct
San Diego, CA, US
9975 Summers Ridge Rd
Show all (9)

Quidel Financials and Metrics

Quidel Revenue

Embed Graph
View revenue for all periods
Quidel's revenue was reported to be $1.66 b in FY, 2020
USD

Revenue (FY, 2020)

1.7b

Gross profit (FY, 2020)

1.3b

Gross profit margin (FY, 2020), %

81.2%

Net income (FY, 2020)

810.3m

EBIT (FY, 2020)

1.1b

Market capitalization (11-Jun-2021)

4.9b

Closing stock price (11-Jun-2021)

114.8

Cash (31-Dec-2020)

489.9m

EV

4.5b
Quidel's current market capitalization is $4.9 b.
USDQ2, 2011

Financial Leverage

1.4 x
Show all financial metrics

Quidel Operating Metrics

FY, 2016

Facilities

2
Show all operating metrics

Quidel Revenue Breakdown

Embed Graph

Quidel revenue breakdown by geographic segment: 83.0% from United States and 17.0% from Other

Quidel Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Quidel Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Quidel Online and Social Media Presence

Embed Graph

Quidel Company Culture

  • Overall Culture

    F

    42/100

  • CEO Rating

    D

    60/100

  • Compensation

    D

    55/100

Learn more on Comparably

Quidel News and Updates

Here’s Why We Believe Quidel Stock Is Undervalued

We believe that the stock price of Quidel, a clinical genetic testing company, looks undervalued at current levels near $108. QDEL stock is actually up just 22% from levels of around $88 it was at on March 23, 2020, when broader markets made a bottom. This compares to the S&P which has risen...

After A Large Decline Is Quidel A Better Bet Compared To Abbott Stock?

We think that Quidel currently is a better pick compared to Abbott. QDEL stock trades at about 3.1x trailing revenues, compared to around 5.6x for Abbott. Does this gap in Quidel’s valuation make sense? To some extent it does, if we look at the future outlook. While both the companies have...

Can Quidel Stock Rebound After A 10% Drop Last Week?

The stock price of Quidel Corporation, a clinical genetic testing company, has seen a 10% drop in just five trading sessions. The decline was driven primarily due to the company’s preliminary report for Q1 with sales estimated to be between $374 million to $376 million, which is well short...

Quidel Stock Looks Attractive After A 20% Drop

The stock price of Quidel Corporation, a manufacturer of diagnostic healthcare products, has seen a large 19% drop over the last ten trading days, while it is down 9% over the last five trading days. We believe the stock, after the recent drop, may trend higher in the near term. The recent drop...

Coronavirus (COVID-19) Update: FDA Issues Authorization for Quidel QuickVue At-Home COVID-19 Test

SILVER SPRING, Md., March 1, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home,...

Outlook on the Nasopharyngeal Swabs Global Market to 2030 - Featuring Titan Biotech, Miraclean Technology and Quidel Among Others

DUBLIN, Dec. 30, 2020 /PRNewswire/ -- The "Nasopharyngeal Swabs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. This report on the global nasopharyngeal swabs market studies past as well...
Show more

Quidel Blogs

Quidel Reports Second Quarter 2019 Financial Results

SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2019-- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2019 .

Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019

Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019 Content Import Fri, 07/26/2019 - 18:00 Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019 July 26, 2019 at 6:00 PM EDT This release i…

Q2 2019 Quidel Corporation Earnings Conference Call

Q2 2019 Quidel Corporation Earnings Conference Call marco.guevara@… Fri, 07/26/2019 - 15:12 Q2 2019 Quidel Corporation Earnings Conference Call Display "add to calendar" true Event Type Earnings Conference Call Click here for …

Kathy P. Ordoñez

Kathy P. Ordoñez marco.guevara@… Wed, 06/26/2019 - 09:18 Kathy P. Ordoñez Former officer of Pacific Biosciences, RainDance Technologies, Inc., Quest Diagnostics, Inc., Celera, and Hoffman-La Roche

Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel’s Triage® MeterPro Instrumented System

Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel’s Triage® MeterPro Instrumented System Content Import Wed, 06/19/2019 - 18:00 Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use Wi…

Quidel Announces Private Exchange Transactions

Quidel Announces Private Exchange Transactions Content Import Tue, 06/04/2019 - 18:00 Quidel Announces Private Exchange Transactions June 4, 2019 at 6:00 PM EDT This release is a backfill from a News Wire General SAN DIEGO--(BUSINESS …

Quidel Frequently Asked Questions

  • When was Quidel founded?

    Quidel was founded in 1979.

  • Who are Quidel key executives?

    Quidel's key executives are Douglas C. Bryant, Ratan Borkar and Robert J. Bujarski.

  • How many employees does Quidel have?

    Quidel has 1,250 employees.

  • What is Quidel revenue?

    Latest Quidel annual revenue is $1.7 b.

  • What is Quidel revenue per employee?

    Latest Quidel revenue per employee is $1.3 m.

  • Who are Quidel competitors?

    Competitors of Quidel include Asklepios, Greystone Health and Surgical Care Affiliates.

  • Where is Quidel headquarters?

    Quidel headquarters is located at 12544 High Bluff Dr, San Diego.

  • Where are Quidel offices?

    Quidel has offices in San Diego, Athens, Beverly, Kornwestheim and in 1 other location.

  • How many offices does Quidel have?

    Quidel has 9 offices.